FCBA Weighs In On Recusal In Myriad Gene Patent Suit

Law360, New York (August 4, 2010, 3:26 PM EDT) -- Without endorsing either side, the Federal Circuit Bar Association has weighed in on a bid by plaintiffs fighting the patentability of human genetic material to exclude a judge, based on remarks he made at an educational conference, from an appeals panel hearing a case over Myriad Genetics Inc.'s patents.

The 2,400-member bar association stressed the importance of judicial participation in educational conferences in an amicus curiae brief filed Tuesday in the U.S. Court of Appeals for the Federal Circuit by Edward Reines of Weil Gotshal &...
To view the full article, register now.